Home - Translational Lung Cancer Research

TLCR Annual Report 2024

Welcome to the 2024 annual report for Translational Lung Cancer Research. In 2024, the TLCR has continued its mission to increase the quality and impact of the journal, and to provide readers with a novel, well-organized, informative, enlightening and educational journal.

We would like to sincerely thank our Editorial Board Members, Guest editors, Reviewers, Authors, Readers for all your supports and contributions to TLCR in 2024, and we look forward to continuing our work with you in the new year.

Interviews with Editorial Board Members

TLCR features a distinguished editorial board, the members of which continue to instill the power of their expertise for the journal’s development. By launching this column, we are glad to introduce to you some of them in the form of interviews, in which they will share their unique career experiences and perspectives. We believe their insights will shed light on the knowledge of related fields.

Interviews with Guest Editors

Over the years, a number of TLCR guest editors have made valuable contributions to the journal. This column features interviews with our guest editors, who graciously share their experience in scientific careers and provide insightful perspectives on the special series.

New Impact Factor for Translational Lung Cancer Research: 4

We are pleased to announce that the Translational Lung Cancer Research (TLCR) has attained its latest impact factor update for the 2023 citation year: 4.

Translational Lung Cancer Research 2023 CiteScore Released: 7.2

We are pleased to announce that the Translational Lung Cancer Research (TLCR) has received its 2023 CiteScore: 7.2, ranking 92 out of 404 journals in the Oncology category.

Furthermore, we are delighted to highlight the remarkable achievements made by all AME journals in the CiteScore ranking.

Interviews with Outstanding Authors (2024)

In 2024, many authors make outstanding contributions to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.

Hereby, we would like to highlight some of our outstanding authors, with a brief interview of their thoughts and insights as authors. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

Reviewer of the Month (2024)

In 2024, TLCR reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

‹ ›

Vol 13, No 12 (December, 2024)

Articles in Press

Past Issues

About tlcr

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

General editorial enquiries:
Email: editor@tlcr.org
Copyright related contact:
Email: permissions@amegroups.com
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com

Original Article

Anatomic and clinical implications of venous drainage variations in superior segment resections for clinical T1N0 non-small cell lung cancer

Chengyu Bian, Chenghao Fu, Wentao Xue, Yan Gu, Hongchang Wang, Wenhao Zhang, Guang Mu, Mei Yuan, Liang Chen, Qianyun Wang, Jun Wang

PDF Pages: 3256-3266 Full Text (120) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

A novel bioassay reflecting response to immune checkpoint inhibitor therapy in non-small cell lung cancer with malignant pleural effusion

Ayako Takigami, Naoko Mato, Koichi Hagiwara, Makoto Maemondo

PDF Pages: 3267-3277 Full Text (73) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Successful long-term outcome of neoadjuvant sequential targeted therapy and chemotherapy for stage III non-small cell lung carcinoma: 10 case series

Masaya Aoki, Ryo Miyata, Go Kamimura, Shoichiro Morizono, Takuya Tokunaga, Aya Harada-Takeda, Koki Maeda, Toshiyuki Nagata, Kazuhiro Ueda

PDF Pages: 3278-3288 Full Text (93) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Health-related quality of life analysis from ENTER, a randomized, controlled phase III trial of whole-brain radiotherapy with and without concurrent erlotinib in NSCLC with brain metastases

Fei Tang, Jingyi Zhang, Zaicheng Xu, Yu Zhang, Xiaoyue Zhang, Yuan Peng, Zhenzhou Yang

PDF Pages: 3289-3302 Full Text (91) Reporting Checklist Trial Protocol Data Sharing Statement Peer Review File COI Form Open Access

Radiomicsmetabolic signature profiles for advanced non-small cell lung cancer with chemoimmunotherapy by reflecting biological function and survival

Yuxin Jiang, Tao Liu, Ke Xu, Wanjun Lu, Qinpei Cheng, Jingyuan Xie, Mo Chen, Xiangyu Bian, Tangfeng Lv, Jiang Wu, Yong Song, Ping Zhan

PDF Pages: 3303-3322 Full Text (76) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Quantitative peripheral live single T-cell dynamic polyfunctionality profiling predicts lung cancer checkpoint immunotherapy treatment response and clinical outcomes

Zuan-Fu Lim, Xiaoliang Wu, Lin Zhu, Heidar Albandar, Maria Hafez, Chenchen Zhao, Mohammed Almubarak, Matthew Smolkin, Hong Zheng, Sijin Wen, Patrick C. Ma

PDF Pages: 3323-3343 Full Text (58) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Osimertinib as a neoadjuvant therapy in resectable EGFR-mutant non-small cell lung cancer: a real-world, multicenter retrospective study

Jialong Li, Youyu Wang, Zerui Zhao, Sihua Wang, Wanpu Yan, Xiaohui Chen, Tianxiang Chen, Pengfei Li, Sheng Wang, Qiang Fang, Lin Peng, Yongtao Han, Jian Tang, Xuefeng Leng

PDF Pages: 3344-3351 Full Text (72) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Development and validation of a nomogram for predicting visceral pleural invasion in patients with early-stage non-small cell lung cancer

Qinyue Luo, Hanting Li, Xiaoqing Liu, Yuting Zheng, Tingting Guo, Jun Fan, Na Wang, Xiaoyu Han, Heshui Shi

PDF Pages: 3352-3363 Full Text (79) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

A non-interventional biomarker study in patients with adenocarcinoma of the lung treated with nintedanib plus docetaxel following progression on chemotherapy and/or immunotherapy: LUME-BioNIS

Martin Reck, Konstantinos Syrigos, Skaidrius Miliauskas, Susan C. van’t Westeinde, Bartomeu Massuti, Hannes Buchner, Alexey V. Salnikov, Robert M. Lorence, Anne-Marit Ellingboe, Thomas Kitzing, Keith Kerr

PDF Pages: 3364-3381 Full Text (88) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Efficacy, safety, and quality of life of dabrafenib plus trametinib treatment in Chinese patients with BRAF^V600E mutation-positive metastatic non-small cell lung cancer

Yun Fan, Jianying Zhou, Yuanyuan Zhao, Yan Yu, Nong Yang, Juan Li, Jialei Wang, Jun Zhao, Zhehai Wang, Jun Chen, Tong Zhu, Haifu Li, Vanessa Q. Passos, Denise Bury-Maynard, Li Zhang

PDF Pages: 3382-3391 Full Text (151) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

A prognostic nomogram of non-small cell lung cancer based on tumor marker inflammatory nutrition score

Yan Feng, Han Qiao, Xiaolei Han, Huaping Tang

PDF Pages: 3392-3406 Full Text (75) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Construction of a neutrophil extracellular trap formation-related gene model for predicting the survival of lung adenocarcinoma patients and their response to immunotherapy

Yuan Wang, Shuang Liang, Qian Hong, Juwei Mu, Yuxin Wu, Kexin Li, Yiling Li, Yue Wu, Xiaoying Lou, Danfei Xu, Wei Cui

PDF Pages: 3407-3425 Full Text (75) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Inhibition of miR-9-3p facilitates ferroptosis by activating SAT1/p53 pathway in lung adenocarcinoma

Anqi Wu, Anping Zhang, Tianyi Wang, Jianle Chen, Jiahai Shi

PDF Pages: 3426-3442 Full Text (63) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Prediction of early lung adenocarcinoma spread through air spaces by machine learning radiomics: a cross-center cohort study

Cong Liu, Ao Meng, Xiu-Qing Xue, Yu-Feng Wang, Chao Jia, Da-Peng Yao, Yun-Jian Wu, Qian Huang, Ping Gong, Xiao-Feng Li

PDF Pages: 3443-3459 Full Text (87) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

A retrospective study of the efficacy and safety of immune checkpoint inhibitors combined with chemotherapy for the treatment of SMARCA4-deficient thoracic tumors

Bin Wang, Heng You, Dongfan Ye, Yuanyue Yi, Yu Liu, Bin Qing, Chuangye Wang, Jincheng Liu, Jian Zhang, Nanbo Wang, Pengfei Wan, Linlin Shen, Zhi Xu

PDF Pages: 3460-3472 Full Text (76) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Effectiveness of artificial intelligence for detecting operable lung cancer on chest radiographs

Hyun Joo Shin, Se Hyun Kwak, Kyeong Yeon Kim, Na Young Kim, Kyungsun Nam, Young Jin Kim, Eun-Kyung Kim, Young Joo Suh, Eun Hye Lee

PDF Pages: 3473-3485 Full Text (82) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Performance of deep learning model and radiomics model for preoperative prediction of spread through air spaces in the surgically resected lung adenocarcinoma: a two-center comparative study

Xiang Wang, Chao Ma, Qinling Jiang, Xuebin Zheng, Jun Xie, Chuan He, Pengchen Gu, Yanyan Wu, Yi Xiao, Shiyuan Liu

PDF Pages: 3486-3499 Full Text (71) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

EGFR inhibitors plus dabrafenib and trametinib in patients with EGFR-mutant lung cancer and resistance mediated by BRAF^V600E mutation: a multi-center real-world experience in China

Wenyue Yang, Xiangran Feng, Jian Ni, Xin Zhang, Hui Yu, Xianghua Wu, Huijie Wang, Xinmin Zhao, Zhihuang Hu, Bo Yu, Yao Zhang, Ying Lin, Yi Xiang, Jialei Wang

PDF Pages: 3500-3512 Full Text (79) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Long-term high fat diet aggravates the risk of lung fibrosis and lung cancer: transcriptomic analysis in the lung tissues of obese mice

Jihyun Park, Danbi Jo, Seo Yoon Choi, Sumin Oh, Yoon Seok Jung, Oh Yoen Kim, Juhyun Song

PDF Pages: 3513-3525 Full Text (90) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Validation of T stage classification strategy for >2 cm ground-glass opacity non-small cell lung cancer: a retrospective cohort study

Yiming Li, Zhenyu Yang, Hui Jie, Liying Zhang, Chenglin Guo, Chengwu Liu, Qiang Pu, Lunxu Liu

PDF Pages: 3526-3537 Full Text (70) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Characteristics of the immune microenvironment and their clinical significance in lung adenocarcinoma patients with different ALK fusion variants

Yinbo Xiao, Hao Wang, Junliang Lu, Junyi Pang, Shiyi Liu, Yang Zhou, Xiaohua Shi, Zhiyong Liang

PDF Pages: 3538-3554 Full Text (83) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Spontaneous ventilation video-assisted thoracoscopic surgery for octogenarian non-small cell lung cancer patients: a non-inferiority study

Yulin Zhao, Xuanzhuang Lu, Runchen Wang, Keyao Dai, Huiwen Yu, Chongde Pan, Jiaqin Zhang, Xianzhe Fan, Yanwei Lin, Hengrui Liang, Jianxing He, Wei Wang, Lan Lan

PDF Pages: 3555-3565 Full Text (94) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Enhancing the prediction of KRAS mutation status in Asian lung adenocarcinoma: a comprehensive approach combining clinical, dual-energy spectral computed tomography, and radiomics features

Jing-Wen Ma, Cai-Xing Yuan, Shan Muhammad, Yan-Mei Wang, Lin-Lin Qi, Jiu-Ming Jiang, Xu Jiang, Lei Miao, Meng-Wen Liu, Xin Liang, Tian Qiu, Li Zhang, Meng Li

PDF Pages: 3566-3578 Full Text (87) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Machine learning-based radiomics for guiding lymph node dissection in clinical stage I lung adenocarcinoma: a multicenter retrospective study

Hao Zhang, Yuan Li, Sikai Wu, Yue Peng, Yang Liu, Shugeng Gao

PDF Pages: 3579-3589 Full Text (80) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Discrepancies in PD-L1 expression, lymphocyte infiltration, and tumor mutational burden in non-small cell lung cancer and matched brain metastases

Yanhui Zhang, Runfen Cheng, Tingting Ding, Jianghua Wu

PDF Pages: 3590-3602 Full Text (73) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Radiotherapy for oligoprogressive disease in non-small cell lung cancer treated with pembrolizumab in first-line setting: a retrospective study

Camille Santonja, Paul Gougis, Elise Dumas, Camille Rolland Debord, Patrick Merle, Aurélie Belliere, Luca Campedel, Baptiste Abbar

PDF Pages: 3603-3615 Full Text (75) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Quantitative evaluation of accumulated and planned dose deviations in patients undergoing gated and non-gated lung stereotactic body radiation therapy patients: a retrospective analysis

Shuangyan Yang, Bin Su, Hui Liu

PDF Pages: 3616-3628 Full Text (81) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Prognostic value of ground-glass opacity on computed tomography for patients with pathological stage IA3 lung adenocarcinoma: a multicenter retrospective cohort study

Chao Chen, Shao-Jun Xu, Xiao-Qiang Du, Jia-Hua Tu, Ren-He Yan, Hui Chen, Duilio Divisi, Sang-Won Um, Yun-Fan Luo, Zhi-Fan Zhang, Cheng-Xiong You, Shao-Bin Yu, Shu-Chen Chen

PDF Pages: 3629-3641 Full Text (55) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Development of an AI model for predicting hypoxia status and prognosis in non-small cell lung cancer using multi-modal data

Lina Zhou, Chenkai Mao, Tingting Fu, Xiao Ding, Luca Bertolaccini, Ao Liu, Junjun Zhang, Shicheng Li

PDF Pages: 3642-3656 Full Text (93) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Identification and validation of pyroptosis patterns with a novel quantification system for the prediction of prognosis in lung squamous cell carcinoma

Xianyu Qin, Jiayan Wu, Fei Qin, Yuzhen Zheng, Junguo Chen, Zui Liu, Jian Tan, Weijie Cai, Shiyun He, Bozhu Jian, Haosheng Zheng, Hongying Liao

PDF Pages: 3657-3674 Full Text (63) Reporting Checklist Peer Review File COI Form Open Access

Efficacy and safety of consolidative thoracic radiotherapy after first-line chemoimmunotherapy in patients with extensive-stage small-cell lung cancer: a retrospective cohort study

Lin Zheng, Yang Yang, Fan Bu, Ruizhi Ye, Fengming Zhang, Zhixiang Ji, Xirong Zhu, Hong Chen, Rongjun Shao, Lidan Liu, Xixi Ying, Lingying Zhu, Enyu Wang, Jifeng Feng, Zhiyong Shi, Jun Fang, Yuezhen Wang, Zhirui Zhou, Guangxian You

PDF Pages: 3675-3691 Full Text (89) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Review Article

Fuel for thought: targeting metabolism in lung cancer

Jaime L. Schneider, SeongJun Han, Christopher S. Nabel

PDF Pages: 3692-3717 Full Text (100) Peer Review File COI Form Open Access

Emerging insights into STK11, KEAP1 and KRAS mutations: implications for immunotherapy in patients with advanced non-small cell lung cancer

Magdalena Knetki-Wróblewska, Kamila Wojas-Krawczyk, Paweł Krawczyk, Maciej Krzakowski

PDF Pages: 3718-3730 Full Text (122) Peer Review File COI Form Open Access

Impact of lymph node involvement in pulmonary carcinoids: a narrative review

Michał Dziedzic, Marcin Cackowski, Maciej Pawlica, Zuzanna Gabrysz, Krzysztof Gofron, Tomasz Marjański

PDF Pages: 3731-3740 Full Text (99) Reporting Checklist Peer Review File COI Form Open Access

Lung cancer organoid-based drug evaluation models and new drug development application trends

Eunyoung Lee, Sang-Yun Lee, Yu-Jeong Seong, Bosung Ku, Hyeong Jun Cho, Kyuhwan Kim, Yongki Hwang, Chan Kwon Park, Joon Young Choi, Sung Won Kim, Seung Joon Kim, Jeong Uk Lim, Chang Dong Yeo, Dong Woo Lee

PDF Pages: 3741-3763 Full Text (156) Peer Review File COI Form Open Access

Mapping the evolution and frontiers of Translational Lung Cancer Research: a bibliometric analysis and literature review

Chong Li, Anqi He, Jing Hu, Yong Xia, Chengqi He, Weihua Zhuang

PDF Pages: 3764-3777 Full Text (63) Reporting Checklist Peer Review File COI Form Open Access

The current landscape and prospects of antibody-drug conjugates for lung cancer brain metastases: a narrative review

Hongxia Zhou, Yi Zeng, Toyoaki Hida, Robert Hsu, Yu Huang, Xiaorong Dong

PDF Pages: 3778-3794 Full Text (72) Reporting Checklist Peer Review File COI Form Open Access

Case Report: iMDT Corner

Long-term survival after combination therapy with atezolizumab in a patient with small-cell lung cancer: a case report

Guangbin Gao, Yajing Wu, Qing Liu, Chang Zhai, Yusuke Inoue, Xinyuan Zhang, Xiaoyan Lv, Wei Zhang, Jun Wang

PDF Pages: 3795-3806 Full Text (71) Reporting Checklist Peer Review File COI Form Open Access

Case Report

A rationale for the poor response to alectinib in a patient with adenocarcinoma of the lung harbouring a STRN-ALK fusion by artificial intelligence and molecular modelling: a case report

Massimo Barberis, Alessandra Rappa, Filippo de Marinis, Giuseppe Pelosi, Elena Guerini Rocco, Yinxiu Zhan, Guido Tiana

PDF Pages: 3807-3814 Full Text (145) Reporting Checklist Peer Review File COI Form Open Access

Editorial Commentary

Targeting a cure in anaplastic lymphoma kinase-positive non-small cell lung cancer

Marie-Frédérique D’Amours, Cheryl Ho

PDF Pages: 3815-3818 Full Text (88) Peer Review File COI Form Open Access

Patient-focused insights: how emotional distress shapes immunotherapy response in non-small cell lung cancer

Federica Pecci, Paolo Tarantino

PDF Pages: 3819-3823 Full Text (415) Peer Review File COI Form Open Access

A potential central nervous system niche for trastuzumab deruxtecan in patients with HER2-expressing non-small cell lung cancer

Anna-Maria Lazaratos, David J. H. Bian, Kevin Petrecca, Marie-Christine Guiot, Matthew Dankner

PDF Pages: 3824-3830 Full Text (69) Peer Review File COI Form Open Access

Can circulating tumor DNA guide treatment de-escalation in metastatic lung adenocarcinoma harboring actionable genomic alterations?

Fabian Acker, Martin Sebastian

PDF Pages: 3831-3834 Full Text (66) Peer Review File COI Form Open Access

Finding the right HARMONi-A

Vladmir Cláudio Cordeiro de Lima, Helano Carioca Freitas

PDF Pages: 3835-3837 Full Text (64) Peer Review File COI Form Open Access

Review Articles

Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?

Yoshihisa Kobayashi, Tetsuya Mitsudomi

Published online: 22 October 2013

PDF Pages: 354-363 Full Text (337501) Open Access

Editorial Commentary

Ground glass nodules with 5 years’ stability can grow after 10-year follow-up: do genetic features determine the fate?

Yoshihisa Kobayashi, Tetsuya Mitsudomi

Published online: 31 December 2019

PDF Pages: S425-S427 Full Text (77418) Open Access

Review Article

Non-small cell lung cancer: current treatment and future advances

Cecilia Zappa, Shaker A. Mousa

Published online: 30 June 2016

PDF Pages: 288-300 Full Text (73500) Open Access

Review Articles

Irreversible EGFR-TKIs: dreaming perfection

Lorenza Landi, Federico Cappuzzo

Published online: 14 January 2013

PDF Pages: 40-49 Full Text (69631) Open Access

Review Article

Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology

Jian-Wei Gao, Stefania Rizzo, Li-Hong Ma, Xiang-Yu Qiu, Arne Warth, Nobuhiko Seki, Mizue Hasegawa, Jia-Wei Zou, Qian Li, Marco Femia, Tang-Feng Lv, Yong Song, written on behalf of the AME Lung Cancer Collaborative Group

Published online: 28 February 2017

PDF Pages: 68-75 Full Text (56153) Open Access

Review Article

Recurrence after surgery in patients with NSCLC

Hidetaka Uramoto, Fumihiro Tanaka

Published online: 28 August 2014

PDF Pages: 242-249 Full Text (44535) Open Access

Review Article

Lung cancer prediction using machine learning and advanced imaging techniques

Timor Kadir, Fergus Gleeson

Published online: 14 June 2018

PDF Pages: 304-312 Full Text (41891) Open Access

Review Article

Targeted therapy for non-small cell lung cancer: current standards and the promise of the future

Bryan A. Chan, Brett G.M. Hughes

Published online: 24 February 2015

PDF Pages: 36-54 Full Text (41764) Open Access

Review Article

Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment

Tianli Zhang, Bing Wan, Yuan Zhao, Chuling Li, Hongbing Liu, Tangfeng Lv, Ping Zhan, Yong Song

Published online: 30 June 2019

PDF Pages: 302-316 Full Text (39541) Open Access

Review Article

The past, present and future of immunotherapy against tumor

Tao Jiang, Caicun Zhou

Published online: 24 June 2015

PDF Pages: 253-264 Full Text (39137) Open Access

Review Article

Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights

Yoshihisa Kobayashi, Chiara Ambrogio, Tetsuya Mitsudomi

Published online: 28 August 2018

PDF Pages: 487-497 Full Text (34712) Chinese (3907) Open Access

Review Articles

KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach

Javier de Castro Carpeño, Cristóbal Belda-Iniesta

Published online: 03 April 2013

PDF Pages: 142-151 Full Text (32100) Open Access

Review Article

The epidemiology of lung cancer

Patricia M. de Groot, Carol C. Wu, Brett W. Carter, Reginald F. Munden

Published online: 14 June 2018

PDF Pages: 220-233 Full Text (31383) Open Access

Review Article

Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey

Jeffrey P. Gregg, Tianhong Li, Ken Y. Yoneda

Published online: 30 June 2019

PDF Pages: 286-301 Full Text (31282) Open Access

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung

Yoon Jin Cha, Hyo Sup Shim

Published online: 11 October 2017

PDF Pages: 508-512 Full Text (30814) Open Access

Review Article

Lung cancer screening: nodule identification and characterization

Ioannis Vlahos, Konstantinos Stefanidis, Sarah Sheard, Arjun Nair, Charles Sayer, Joanne Moser

Published online: 14 June 2018

PDF Pages: 288-303 Full Text (30163) Open Access

Consensus

Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou)

Jianxing He, Hengrui Liang, Wei Wang, Andrey Akopov, Alberto Aiolfi, Keng-Leong Ang, Luca Bertolaccini, Kaican Cai, Qingdong Cao, Baojun Chen, Chang Chen, Chun Chen, Donglai Chen, Fengxia Chen, Jun Chen, Lei Chen, Mingwu Chen, Yongbing Chen, Zhuxing Chen, Chao Cheng, Dong Cui, Fei Cui, Tianyang Dai, Qinglong Dong, Paolo A. Ferrari, Raja M. Flores, Junke Fu, Soichiro Funaki, Marios E. Froudarakis, Xiangfeng Gan, Mingfei Geng, Jialong Guo, Qiang Guo, Yongtao Han, Jintao He, Kaiming He, Kyoji Hirai, Jian Hu, Shuqiao Hu, Jian Huang, Jun Huang, Wenfa Jiang, Kyung Soo Kim, Gabor Kiss, Fanyi Kong, Lan Lan, Xuefeng Leng, Bin Li, Gaofeng Li, Hecheng Li, Hefei Li, Heng Li, Jiwei Li, Xiaoqiang Li, Shuben Li, Yinfen Li, Zhuoyi Li, Yi Liang, Lixia Liang, Wenhua Liang, Yongde Liao, Wanli Lin, Xu Lin, Hongxu Liu, Hui Liu, Jixian Liu, Jun Liu, Xiang Liu, Zihao Liu, Xingzhao Lu, Qingquan Luo, Naiquan Mao, Qi Pan, Dazhi Pang, Jun Peng, Jun Peng, Eugenio Pompeo, Rulin Qian, Kun Qiao, Bassam Redwan, Zi Sang, Wenlong Shao, Jianfei Shen, Weiyu Shen, Sook-Whan Sung, Wenfang Tang, Tianhu Wang, Guangsuo Wang, Haitao Wang, Huien Wang, Jiyong Wang, Wen Wang, Yongyong Wang, Zhenyuan Wang, Li Wei, Wei Wei, Hao Wu, Jie Wu, Zhaohua Xia, Chenyang Xu, Enwu Xu, Hai Xu, Ning Xu, Quan Xu, Rongyu Xu, Shun Xu, Chaokun Yang, Hanyu Yang, Shengli Yang, Jun Yi, Guangjian Zhang, Hao Zhang, Jia Zhang, Man Zhang, Xiao Zhang, Yajie Zhang, Zhe Zhang, Zhifeng Zhang, Honglin Zhao, Jian Zhao, Xiaodong Zhao, Jianping Zhou, Yanran Zhou, Chengchu Zhu, Shaojin Zhu, Xinhai Zhu, Jian Cui, Yubo Yan, Ke-Neng Chen

Published online: 28 August 2021

PDF Pages: 3503-3519 Full Text (29138) COI Form Open Access

Review Articles

New TNM classification: achievements and hurdles

Peter Goldstraw

Published online: 17 August 2013

PDF Pages: 264-272 Full Text (28729) Open Access

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto

Published online: 19 April 2015

PDF Pages: 156-164 Full Text (28226) Open Access

Review Articles

Angiogenesis in cancer: anti-VEGF escape mechanisms

Gerald W. Prager, Marina Poettler, Matthias Unseld, Christoph C. Zielinski

Published online: 18 February 2012

PDF Pages: 14-25 Full Text (28107) Open Access

Full Most Read article list >>

Original Article

Prognostic value of Twist in lung cancer: systematic review and meta-analysis

Junli Zeng, Ping Zhan, Guannan Wu, Wen Yang, Wenjun Liang, Tangfeng Lv, Yong Song

BRAF mutations in non-small cell lung cancer

Peter P. Luk, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina Selinger, Trina Lum, Steven Kao, Sandra A. O’Toole, Wendy A. Cooper

The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer

Shu Wang, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina I. Selinger, Sandra A. O’Toole, Wendy A. Cooper

Itraconazole can inhibit malignant pleural effusion by suppressing lymphangiogenesis in mice

Yunfen Wang, Yanwen Yao, Hongbin Liu, Xingqun Ma, Tangfeng Lv, Dongmei Yuan, Xinwu Xiao, Jie Yin, Yong Song

Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer

Fangfang Chen, Yanwen Yao, Chunyan Ma, Xingqun Ma, Zhaofeng Wang, Tangfeng Lv, Xinwu Xiao, Jie Yin, Yong Song

Advanced proton beam dosimetry part II: Monte Carlo vs. pencil beam-based planning for lung cancer

Dominic Maes, Jatinder Saini, Jing Zeng, Ramesh Rengan, Tony Wong, Stephen R. Bowen

The cytokinesis-blocked micronucleus assay as a novel biomarker for selection of lung cancer screening participants

Randa A. El-Zein, Carol J. Etzel, Reginald F. Munden

The use of TCP based EUD to rank and compare lung radiotherapy plans: in-silico study to evaluate the correlation between TCP with physical quality indices

Abdulhamid Chaikh, Jacques Balosso

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto

Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement

Hyojin Kim, Jin-Haeng Chung

Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer

Haoran Zhai, Wenzhao Zhong, Xuening Yang, Yi-Long Wu

Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations—a review

Erin L. Stewart, Samuel Zhixing Tan, Geoffrey Liu, Ming-Sound Tsao

Clinical trials for lung cancer in China

Fei-Yu Niu, Wen-Zhao Zhong, Qing Zhou, Yi-Long Wu

Recurrence after surgery in patients with NSCLC

Hidetaka Uramoto, Fumihiro Tanaka

Prognostic markers in lung cancer: is it ready for prime time?

Chang-Qi Zhu, Ming-Sound Tsao

Potential biomarkers for lung cancer screening

Gabriella Sozzi, Mattia Boeri

Particle therapy in non-small cell lung cancer

Zhongxing Liao, Charles B. Simone II

Computer Aided Nodule Analysis and Risk Yield (CANARY) characterization of adenocarcinoma: radiologic biopsy, risk stratification and future directions

Ryan Clay, Srinivasan Rajagopalan, Ronald Karwoski, Fabien Maldonado, Tobias Peikert, Brian Bartholmai

Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer

Neil K. Taunk, Andreas Rimner, Melissa Culligan, Joseph S. Friedberg, Julie Brahmer, Jamie Chaft

Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors

Suchit H. Patel, Andreas Rimner, Roger B. Cohen

Intraoperative near-infrared imaging of mesothelioma

Gregory Thomas Kennedy, Andrew Newton, Jarrod Predina, Sunil Singhal

BAP1, a tumor suppressor gene driving malignant mesothelioma

Mitchell Cheung, Joseph R. Testa

Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation

Jonathan E. Schoenhals, Steven N. Seyedin, Clark Anderson, Eric D. Brooks, Yun R. Li, Ahmed I. Younes, Sharareh Niknam, Ailin Li, Hampartsoum B. Barsoumian, Maria Angelica Cortez, James W. Welsh

Diagnostic and prognostic biomarkers for malignant mesothelioma: an update

Zhongjian Chen, Giovanni Gaudino, Harvey I. Pass, Michele Carbone, Haining Yang

Immunotherapy for malignant pleural mesothelioma: current status and future directions

Jordan Dozier, Hua Zheng, Prasad S. Adusumilli

Biology and clinical significance of circulating tumor cell subpopulations in lung cancer

Linda O’Flaherty, Harriet Wikman, Klaus Pantel

Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time?

Emma Pailler, Vincent Faugeroux, Marianne Oulhen, Cyril Catelain, Françoise Farace

Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer

Sumitra Mohan, Francesca Chemi, Ged Brady

Biophysical technologies for understanding circulating tumor cell biology and metastasis

Derrick W. Su, Jorge Nieva

Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer

Marianna Gallo, Antonella De Luca, Monica Rosaria Maiello, Amelia D’Alessio, Claudia Esposito, Nicoletta Chicchinelli, Laura Forgione, Maria Carmela Piccirillo, Gaetano Rocco, Alessandro Morabito, Gerardo Botti, Nicola Normanno

Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer

Salma K. Jabbour, Abigail T. Berman, Charles B. Simone II

Editorial

An alternative way to initiate Notch1 signaling in non-small cell lung cancer

Yi-Lin Yang, David Jablons, Liang You

Combination MET- and EGFR-directed therapy in MET-overexpressing non-small cell lung cancers: time to move on to better biomarkers?

Fernando C. Santini, Siddharth Kunte, Alexander Drilon

Systematic Review and Meta-analysis

Association of the metformin with the risk of lung cancer: a meta-analysis

Li Wang, Yong Song, Guan-Nan Wu, Dong-Mei Yuan

China Lung Cancer Research Highlight

Dll4/Notch1 signaling from tip/stalk endothelial cell specification to stroma-dependent lung tumor inhibition: a flavor of Dll4/Notch1 pleiotropy in tumor cell biology

Maria Felice Brizzi, Paola Defilippi

Editorials

Dulanermin in cancer therapy: Still much to do

Cristina Quintavalle, Gerolama Condorelli

Review Articles

EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data

Bradley T. Clifford, Pingfu Fu, Nathan A. Pennell, Balazs Halmos, Rom S. Leidner

Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung

Pedro Mendez, Jose Luis Ramirez

Role of HGF/MET axis in resistance of lung cancer to contemporary management

Kanwal Pratap Singh Raghav, Ana Maria Gonzalez-Angulo, George R. Blumenschein Jr

Circulating soluble intercellular adhesion Molecule-1 in lung cancer: a systematic review

Xiaoling Gu, Chunyan Ma, Dongmei Yuan, Yong Song

Ceritinib

Clinical development and approval of second generation ALK inhibitors for ALK rearranged lung cancer

Daniel B. Costa

Onartuzumab plus erlotinib

Targeting MET in NSCLC: looking for a needle in a haystack

Lorenza Landi, Federico Cappuzzo

Nivolumab

Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients with advanced non-small cell lung cancer

Arun Rajan, James L. Gulley

Brief Report

The role of Imaging and Radiation Oncology Core for precision medicine era of clinical trial

Ying Xiao, Mark Rosen

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung

Yoon Jin Cha, Hyo Sup Shim

Immunohistochemistry for predictive biomarkers in non-small cell lung cancer

Mari Mino- Kenudson

Below are the latest Translational Lung Cancer Research articles published online ahead of print publication.

Original Article

MS4A15 gene expression as a prognostic marker for clinical outcomes in lung adenocarcinoma

Lingxiao Qiu, Tingcheng Li, Bin Qing, Cailin Zhao, Xinye Zhang, Satoshi Watanabe, Armida D’Incecco, Ninh M. La-Beck, Tracy L. Leong, Chuangye Wang, Jincheng Liu, Qi Li, Li Bai, Gang Liu, Xueping Liu, Zhi Xu

Published online: 16 December 2024

Journal Highlight more

Translational Lung Cancer Research is an international, peer-reviewed, open-access journal indexed by Science Citation Index Expanded (SCIE) and PubMed/PubMed Central, focusing on cutting-edge development on the transition from preclinical to clinical research, including but not limited to multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer and relevant thoracic diseases.